430 related articles for article (PubMed ID: 15513335)
21. Impact of sleep disturbances in inflammatory bowel disease.
Ranjbaran Z; Keefer L; Farhadi A; Stepanski E; Sedghi S; Keshavarzian A
J Gastroenterol Hepatol; 2007 Nov; 22(11):1748-53. PubMed ID: 17914945
[TBL] [Abstract][Full Text] [Related]
22. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
[TBL] [Abstract][Full Text] [Related]
23. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression.
Afsar B; Elsurer R; Yilmaz MI; Eyileten T; Yenicesu M
Nephrology (Carlton); 2010 Mar; 15(2):197-202. PubMed ID: 20470279
[TBL] [Abstract][Full Text] [Related]
24. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life among patients with primary sclerosing cholangitis.
Haapamäki J; Tenca A; Sintonen H; Barner-Rasmussen N; Färkkilä MA
Liver Int; 2015 Sep; 35(9):2194-201. PubMed ID: 25546575
[TBL] [Abstract][Full Text] [Related]
26. [Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease].
Kovács Z; Kovács F
Psychiatr Hung; 2007; 22(3):212-21. PubMed ID: 18167418
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
[TBL] [Abstract][Full Text] [Related]
28. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
30. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
31. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
Karling P; Danielsson A; Adolfsson R; Norrback KF
Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
[TBL] [Abstract][Full Text] [Related]
32. Immune-mediated diseases in primary sclerosing cholangitis.
Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
[TBL] [Abstract][Full Text] [Related]
33. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer.
Brown DJ; McMillan DC; Milroy R
Cancer; 2005 Jan; 103(2):377-82. PubMed ID: 15558809
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
Ngu JH; Gearry RB; Wright AJ; Stedman CA
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
[TBL] [Abstract][Full Text] [Related]
35. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
Okolicsanyi L; Fabris L; Viaggi S; Carulli N; Podda M; Ricci G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
[TBL] [Abstract][Full Text] [Related]
36. An initial report of sleep disturbance in inactive inflammatory bowel disease.
Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
[TBL] [Abstract][Full Text] [Related]
37. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
Bosch DE; Yeh MM
Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
[TBL] [Abstract][Full Text] [Related]
38. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
[TBL] [Abstract][Full Text] [Related]
39. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease.
Barratt SM; Leeds JS; Robinson K; Shah PJ; Lobo AJ; McAlindon ME; Sanders DS
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):159-65. PubMed ID: 21178777
[TBL] [Abstract][Full Text] [Related]
40. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
